1 / 4

Epigenetics Drugs and Diagnostic Technologies Market Size, Share, Analysis, Industry Report, and Forecast - 2019-2025

<br>An increase in the aging population, as there is a strong correlation between cancer and aging is the factor that drives the growth of the epigenetics drugs and diagnostic technologies market during the forecast period. As per the WHO, it is expected that population over the age of 60 years that would double from 11% in 2000 to 22% in 2050 and people aged 60 and above are more prone to cancer.

pooja99
Download Presentation

Epigenetics Drugs and Diagnostic Technologies Market Size, Share, Analysis, Industry Report, and Forecast - 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Epigenetics Drugs and Diagnostic Technologies Market Size, Share, Analysis, Industry Report, and Forecast - 2019-2025 Request a free sample of our report on Epigenetics Drugs and Diagnostic Technologies Market: https://www.omrglobal.com/request-sample/epigenetics-drugs-and-diagnostic- technologies-market ------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. An increase in the aging population, as there is a strong correlation between cancer and aging is the factor that drives the growth of the epigenetics drugs and diagnostic technologies market during the forecast period. As per the WHO, it is expected that population over the age of 60 years that would double from 11% in 2000 to 22% in 2050 and people aged 60 and above are more prone to cancer. Thus, countries are advocating early detection of cancer through screening kits such as Epi ProLung and Epi Procolon that are fuelling the growth of the epigenetics drugs and diagnostic technologies market over the forecast period. Cancer epigenetics is a practical resource for scientists that are engaged in testing, development of epigenetic cancer drugs and discovery. Epigenetic modifications have considerable implications for translational science as a biomarker for prognosis and diagnosis. Epigenetic modifications are reversible and epigenetic players are found mutated in different cancers, therefore, they provide attractive therapeutic targets. Request a free sample of our report on Epigenetics Drugs and Diagnostic Technologies Market: https://www.omrglobal.com/request-sample/epigenetics-drugs-and-diagnostic- technologies-market High prevalence of cancer and other chronic diseases are some of the key factors expected to boost the market. As per the estimation by National Cancer Institute (NIH),the estimated number of cancer deaths in the U.S. is around 163.5 per 100,000 men and women per year. Moreover, the International Cancer Genome Consortium (ICGC) is mainly focused on obtaining epigenomic changes, genomic description and transcriptomic changes in different types of cancers. The Encyclopedia of DNA Elements (ENCODE) project was launched by the US national human genome research institute with the aim to identify all the human genome sequence elements. A full report of Epigenetics Drugs and Diagnostic Technologies Market is available at https://www.omrglobal.com/industry-reports/epigenetics-drugs-and-diagnostic- technologies-market The epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs. Epigenetic mechanisms are widely involved in human diseases. The reversible nature of epigenetic changes has led to the emergence of novel epigenetic therapeutic approaches. Epigenetics is defined by inherited somatic changes that are not related to changes in the DNA sequence. So, the epigenetic outlook of a cell is determined by the status of DNA methylation, histones covalent modifications, chromatin structure, and non-coding RNAs and networking with each other. Global Epigenetics Drugs and Diagnostic Technologies Market- Segmentation By Type Histone Deacetylase (HDAC) Inhibitors DNA Methyltransferase (DNMT) Inhibitors   By Product Reagents Kits Instruments Enzymes Services     

  3. By Application Cancer Disease Inflammatory Diseases Infectious Diseases Cardiovascular Diseases Metabolic Diseases Other       By Region North America The US Canada   Europe Germany UK France Spain Italy Rest of Europe       Asia-Pacific China Japan India Rest of Asia-Pacific     Rest of the World Latin America Middle East Africa   Company Profiles ·4SC AG ·AbbVie, Inc. ·Abcam plc ·Aurobindo Pharma USA, Inc. ·Celgene Corp. ·CellCentric, Ltd. ·Celleron Therapeutics, Ltd.

  4. ·Eisai, Inc. ·EpiGentek Group, Inc. ·Epizyme, Inc. For https://www.omrglobal.com/report-customization/epigenetics-drugs-and-diagnostic- technologies-market more customized data, request for report customization @ About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related